Concepedia

Deborah Francis

DF

Statistics

Publications

4

Citations

1.8K

H-Index

4

Active since

2004

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Deborah Francis is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, pharmacology, and medicine.

Publications per year

2004–2007

4

Publications

4

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

, , +17

Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen

Aman U. Buzdar, Vicente Valero, Nuhad K. Ibrahim et al. · Clinical Cancer Research · 2007 · 469 citations

, , +10

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

Edgardo Rivera, Christina Meyers, Morris D. Groves et al. · Cancer · 2006 · 154 citations · Full text

, , +17

Pilot Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of the Combination of Exemestane and Tamoxifen

Edgardo Rivera, Vicente Valero, Deborah Francis et al. · Clinical Cancer Research · 2004 · 18 citations · Full text

, , +17

1–4 of 4